Dr. James Anderson received his Ph.D. at Oregon State University in 1967. In 1976, he graduated from the Case Western Reserve University School of Medicine with an M.D. degree and finished his Anatomic Pathology residency at the Institute of Pathology of University Hospitals of Cleveland in 1979. Following the completion of his residency, Dr. Anderson joined the faculty of the Institute of Pathology at Case Western Reserve University. Dr. Anderson has worked in the area of biomaterials, medical devices, and prostheses for the past 40 years and his current activities range from the clinical pathology evaluation of retrieved implants from humans to fundamental studies of cellular interactions with biomaterials.
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement; include BBC, ITV, WSJ, CNN, and many more. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. He has commercialised a novel functionalised graphene oxide for medical and other industrial applications. He also commercialised new biodegradable nanocomposite materials for medical and other industrial applications. He is British citizen and completed his school in UK (concord college) and his scientific training at London University.
Debora is a doctor and CEO of the Iberoamerican Institute of Bioregenerative Medicine (IBIOMER). She has been working with autologous stem cell transplants from bone marrow (BMSC) in humans for 5 years. Her research focuses on clinically correlating the angioplastic and immunoregulatory power of autologous BMSC transplants without culture in patients with endothelial dysfunction/inflammation as in diabetes mellitus. These present reduction of circulating endothelial progenitor cells which preceding macro and microvascular complications and autonomic or somatic neuropathic damage. Their study, under multidisciplinary management of clinical cases of diabetic foot with perforating lesions to states of necrosis grade III / IV, reached, as a result, the total regeneration of tissues, 30 days after the first autotransplant with previous physiological conditioning in vivo, to promove the angiogenic activation. She works hard to promote to IBIOMER and the translational research in Venezuela with multicenter studies to extend other Latinoamerican countries.
Mohamed Abd Ellatif Mohamed Said completed his studies at Mansoura University (1985-1995), Toronto University (2001). Then he went back to Mansoura University and joined as a Professor in Medical Biochemistry and Molecular Biology, Faculty of Medicine. In 2007 he joined as a professor of Clinical Biochemistry and Molecular Biology, College of Medicine, King Khalid University, Kingdom of Saudi Arabia during the period from 2/9/2007 till now. He has more than 55 research papers in national and international journals. He attended more than 43 international and national workshops and conferences. He is an active reviewer for many scientific journals and conferences. He handled 8 master thesis and 7 Ph.D. thesis.
Majid Ghassemi is a Professor of Mechanical Engineering Department at the K. N. Toosi University of Technology in Tehran, Iran. He has over 20 years of academic and industrial experience and served as the President of the K. N. Toosi University of Technology from 2010 through 2013. Professor Ghassemi has also served in several public and private boards and panels and supervised several undergraduate, masters and PhD students, published several books and many journal and conference papers. He is currently Editor-in-Chief and Editorial Board member for many international journals. He also serves as member in several international conferences. Professor Ghassemi received his Ph.D. in Mechanical Engineering from Iowa State University in 1993.
Biomaterials, Regenerative Medicine, Tissue Engineering and Nanomedicine
Dr Gilson Khang was born in 1960 in South Korea, where he obtained his degrees at the Inha Univ (BS and MS). In 1987, he joined the Dr Hai Bang Lee’s Biomaterials Lab at KRICT (Deajeon, Korea). He was studying for PhD degree at the Department of Biomedical Engineering, The Univ of Iowa (Iowa City, IA, USA) from 1991-1995 under the guidance of Prof Joon B Park. His academic career started at the Department of PolymerNano Science and Technology at Chonbuk National University (CBNU) and then tenured by Full Professor in 2009. From 2006 to 2011, he was the PI of BK-21 (Brain Korea 21 Project) and WCU (World Class University, 3MUD/yr for 5 years) Program at CBNU supported by KMEST. He was Chair Professor in the Department of BIN Fusion Technology of WCU program of CBNU. He was the one of Founder Members of Asian Tissue Engineering Society (ATES) and one of Founder Members of TERMIS-AP Chapter. Prof. Khang was General Secretary and Treasurer for 2005~2009 of TERMIS-AP Chapter and now served as a council member for TERMIS-AP. Recently, he is TERMIS-AP Past-President, & TERMIS Global President-Elect (2016~2018). He has co-authored or edited 30 books. He has published 600 original research papers and 200 editorials, reviews or chapters in books. His papers were cited 15,520 times. (h-index >68) and his major scientific contribution has been to appreciate and analyze the importance of natural/synthetic hybrid scaffold to reduce the host inflammation reaction as well as the commercialization for tissue engineered products as cartilage, bone, retinal pigment epithelium, cornea endothelium, etc. His international collaboration network is really worldwide and tight over 7 countries and 15 Universities. He is engaging the Visiting Professor of Tsinghua Univ, Peking Univ, Zhejiang Univ, China and Wake Forest Institute of Regenerative Medicine, USA.
Tissue engineering, Mesenchaymal stem cell, and Drug delivery system
Pathology and Stem cells
Prof. Andrzej Lange, MD, FRCP graduated with a medical degree with distinction from the Medical School in Wroc?aw, Poland is a professor in the Institute of Immunology and Exp Therapy of the Polish Academy of Sciences and a founder and head of the Lower Silesian Center of Cellular Transplantation in Wroc?aw. His international experience started in 1973 – 1974 as a Leverhulme Fellow in the Middlesex Hospital Medical School, London. He has been a visitor and lectured in a number of European and North American scientific institutions. Known from his activity in the field of bone marrow transplantation and regenerative medicine. Prof. Lange was awarded several scientific distinctions and served to a number of National and European institutions were also active in co-editing journals. He is an author and co-author of 249 scientific papers, in peer-reviewed journals with a cumulative IF of 270 in the years 1995–2017